ARTICLE | Clinical News

Soligenix preclinical data

March 5, 2012 8:00 AM UTC

In dogs exposed to lethal doses of total body irradiation, SGX202 administered 24 hours after exposure and daily until GI recovery plus autologous bone marrow transplant significantly improved median survival vs. untreated controls (>87 vs. 8 days, p=0.04). The study was supported by a $1 million grant from NIH's National Institute of Allergy and Infectious Diseases (NIAID). ...